University of Alberta to develop sound system to de-stress ICU patients
The system will assess various physical attributes of an individual and then play customised music to induce relaxation.
Neurology
Inscopix, NeuroNexus to develop electrophysiology and imaging device
The collaboration will seek a better understanding of brain health and support the development of...
FDA labels recall of Zimmer’s ROSA One 3.1 Brain Application as Class I
Zimmer Biomet recalled the ROSA One 3.1 Brain Application due to software errors.
DZNE and UMG team detect molecules in blood indicating impending dementia
Scientists detected three microRNAs that were linked to mental performance.
FDA grants breakthrough designation to Alpha Tau’s device for GBM treatment
Alpha DaRT also received breakthrough device designation to treat skin cancer in June.
MYND forms diagnostic subsidiary to market tests for psychiatric disorders
MYND Diagnostics will carry out trials to detect a marker for diagnosing and monitoring depression in response to treatment.
UAB team to trial FDA-cleared device for traumatic brain injury monitoring
Infrascanner uses near-infrared spectroscopy to detect intracranial hematomas based on differential light absorption.
UK DRI researchers develop blood test to detect brain damage
During the study, the blood test helped to predict further nerve cell degeneration up to a year after the injury.
University of Bath team develops EEG test for early Alzheimer’s diagnosis
The Fastball EEG test could potentially aid in reducing the age of Alzheimer’s diagnosis by up to five years.
NeuroOne secures 510(k) clearance from US FDA for Evo sEEG Electrode
The clearance will enable NeuroOne to market Evo sEEG Electrode for uses of less than 24 hours.
NIH awards $10m grant for Synchron’s brain computer interface study
The study, referred to as the COMMAND trial, will include six severely paralysed patients.
